Dual Approach Using Unbiased Proteomics and Multiplexed Immunofluorescence for the Detection of Markers Predictive for Immunotherapy in Melanoma Patients - Biognosys

Dual Approach Using Unbiased Proteomics and Multiplexed Immunofluorescence for the Detection of Markers Predictive for Immunotherapy in Melanoma Patients

Poster 1267/14 presented at AACR 2022

Presenter: Jakob Vowinckel
Session: PO.CL11.07 Biomarkers Predictive of Therapeutic Benefit 2
Date: April 11

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    Spectronaut® 16

    The Deepest Proteome
    Coverage Available

    New: Spectronaut® 16

    The Deepest Proteome Coverage Available

    learn more